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Summary
Objective: To investigate the effect in OA (Osteoarthritis) susceptibility of putative damaging changes in ADAM (A Disintegrin And Metallopro-
tease) and ADAMTS (ADAM with ThromboSpondin motif) proteases.
Methods: Non-synonymous single nucleotide polymorphisms (nsSNP) in 18 ADAMTS and 31 ADAM genes were analyzed with two software
applications for prediction of functional damage. Four putative damaging nsSNP were found in ADAMTS2, ADAMTS14, ADAMTS16 and
ADAM12, respectively. These nsSNPs were analyzed in case-control sample collections with a variety of phenotypes totalling 3217 OA
patients and 2214 healthy controls, all of them Caucasians.
Results: No statistically signiﬁcant differences were found in ADAMTS2, ADAMTS16 and ADAM12 nsSNPs. Conversely, the rare allele of the
rs4747096 nsSNP in ADAMTS14 was overrepresented in women requiring joint replacement because of knee OA (O.R.M-H (odds ratio.
Mantel-Haenszel)¼ 1.41, 95% C.I.¼ 1.1e1.8; P¼ 0.002) and in patients with symptomatic hand OA (O.R.¼ 1.37, 95% C.I.¼ 1.0e1.9;
P¼ 0.047). A non signiﬁcant increase in the frequency of the same allele was also found in patients with hip OA requiring prosthesis
(O.R.M-H¼ 1.14, 95% C.I.¼ 1.0e1.3; P¼ 0.08). No association was found with other OA phenotypes.
Conclusion: Our ﬁndings implicate ADAMTS14 in OA, speciﬁcally in knee OA requiring joint replacement in women and, possibly, in hand OA.
Independent association of ADAMTS14 genetic variation to knee OA in women has been communicated. ADAMTS14 involvement, if con-
ﬁrmed, will open a new area of interest in OA pathogenesis because of its role in the maturation of collagen ﬁbers.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Genetic susceptibility, Osteoarthritis, Matrix metalloproteases, Non-synonymous polymorphisms.Introduction
Primary osteoarthritis (OA) is the most prevalent form of ar-
thritis and a cause of important handicap among the elderly.
This situation is compounded by our incomplete knowledge
of OA molecular mechanisms and etiological factors. The
latter are complex, including a wide array of non-genetic
factors and a multiplicity of weak genetic factors1e3. Some
of the speciﬁc OA genetic factors have already been identi-
ﬁed. Notable examples are polymorphisms in asporin4,
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321involved in controlling growth and differentiation pathways,
asporin by regulating the availability of free TGF-b7; FRZB
as a soluble inhibitor of Wnt ligands; and GDF5 as a carti-
lage growth and differentiation factor. Many other genetic
variants have shown association to OA but they have not
been sufﬁciently conﬁrmed. Further research is needed to
replicate previous ﬁndings and to identify new OA genetic
factors.
The genes encoding members of the two large families of
proteases ADAM and ADAMTS are of interest in OA as
possible genetic factors8. Proteins of these families share
two functional domains, a metalloprotease domain, the ac-
tive site common to all metalloproteases, and a disintegrin
domain that mediates adhesion. In addition, the ADAMTS
proteins include thrombospondin motifs. Most ADAMs are
membrane-bound proteases and their best known functions
are ectodomain shedding and regulation of cell adhesion,
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Ectodomain shedding, the proteolytic cleavage of extracel-
lular protein domains, affects growth factors, cytokines and
cell adhesion molecules. Some members of the ADAM fam-
ily can be involved in OA. For example, ADAM8 and
ADAM12 are involved in osteoclast differentiation11,12,
ADAM10 is implicated in cell fate determination of osteo-
blasts13, ADAM15 enhances chondrocyte adhesion to col-
lagen, promotes chondrocyte survival and protects from
experimental OA14; and ADAM17 releases TNF-a form its
membrane-bound precursor15. The ADAMTS family con-
tains all the known aggrecanases (ADAMTS1, -4, -5, -8,
-9, -15). These enzymes cut the aggrecan core protein at
a particular site that seems critical for cartilage damage16.
One of them, ADAMTS5 is necessary for cartilage damage
in murine models of arthritis17,18. However, it is unknown if
ADAMTS5 is as crucial in humans as in these models19.
We have recently shown that genetic variation in this
gene seems irrelevant for OA predisposition20. In addition,
some of the ADAMTS are able to degrade other matrix com-
ponents apart from aggrecan and three of them, ADAMTS2,
-3 and -14, are involved in processing of collagen precur-
sors, procollagen types I, II or III, by cleaving their N-termi-
nal propeptides. Also indicative of the possible relevance of
some ADAM or ADAMTS proteases for OA are studies of
mRNA expression and of genetic association. Systematic
analyses of gene expression by microarray hybridization
and speciﬁc studies by quantitative PCR (qPCR) have
shown a wide array of signiﬁcant differences between con-
trol and OA cartilage21e24. In addition, genetic association
of an non-synonymous single nucleotide polymorphisms
(nsSNP) in ADAM12 to knee OA has been reported25.
Here, we have examined all the ADAMTS and ADAM
members looking for nsSNPs. Those predicted to be dam-
aging for protein function were studied in a variety of OA
phenotypes. An nsSNPs in ADAMTS14 showed associa-
tion to OA in some of them, most notably knee OA requiring
joint replacement.Material and methods
Patients and controls: Six already described sample collections of Euro-
pean Caucasians were used20,26e30. They were divided in two sets, a ﬁrst
set included samples with hand OA or with knee or hip OA requiring total joint
replacement in which all single nucleotide polymorphisms (SNPs) were ana-
lyzed in the Santiago laboratory. The second set included other OA pheno-
types in which only the rs4747096 SNP was studied in different laboratories.
The ﬁrst set included samples from three collections, the Hospital Clinico de
Santiago in Spain; the Institute of Musculoskeletal Sciences, University of
Oxford in the UK; and the Departments of Biology and Genetics and of Or-
thopaedics, University of Thessaly in Greece. These three collections of
samples include knee or hip OA patients that have undergone total joint re-
placement (total knee replacement (TKR) and total hip replacement (THR)
groups, respectively) due to the severity of their lesions. Exclusion of inﬂam-
matory, posttraumatic or postseptic arthritis, as well as cases suggestive of
dysplasia was performed. The Santiago collection also included patients with
hand OA according to the American College of Rheumatology (ACR) classi-
ﬁcation criteria (HOA; 242 subjects, 213 women, 27 men and 2 unrecorded;
mean age 61 years, range 32e88). Other patients of this collection were 307
subjects of the THR group (185 women and 122 men; mean age 68 years,
range 55e84) and 262 of the TKR group (211 women and 51 men; mean
age 68 years, range 55e80). Patient evaluation included review by a rheuma-
tologist of a speciﬁc questionnaire, clinical history and radiographs previous
to surgery. The 294 selected controls (115 women and 179 men; mean age
68 years, range 55e94) did not show clinical manifestations of OA (absence
of chronic pain or restriction of mobility in the two years before recruitment,
no hand enlargements or deformities, and no previous medical evaluation
as OA). All of the subjects in this collection were of Caucasian Spanish an-
cestry. The Oxford’s collection was of 1105 THR samples (629 females and
476 males), 360 TKR samples (196 women, 164 men). All patients have
a Kellgren/Lawrence (K/L) score of >2 and >90% had a K/L score of 3 or
4. The average age of patients was 65 years (range 55e85 years). The698 controls of this collection (356 women, 342 men) had no signs or symp-
toms of arthritis or joint disease (pain, swelling, tenderness, or restriction of
movement). The average age of the controls was 69 years (range 55e89
years). All were UK Caucasians. The Thessaly’s collection included 159
TKR patients (139 women with mean age 68 years and range 48e92, and
20 men with mean age 72 years and range 62e85). All of them had K/L
score >2 and 92 % had a 3e4 score. The control population consisted of
193 subjects (137 women with mean age 68 years and range 44e87, and
56 men with mean age 70 years and range 46e88), who had no clinical
OA and that showed a K/L score of 0. All individuals were of Greek origin liv-
ing in the district of Thessaly.
The second set was made of three collections: Corunna, Leiden and Lon-
don. The ﬁrst included 265 clinically symptomatic and radiographically con-
ﬁrmed knee OA patients (KOA; 222 women and 43 men; mean age 67
years, range 30e96) from the Hospital Juan Canalejo, A Corunna in Spain
(this collection did not include controls). All of them were Spanish Cauca-
sians. The Leiden collection was made of 358 subjects with familial OA at
multiple sites (292 women and 66 men of Dutch ancestry sib pairs; mean
age 60 years, range 43e79) from the Genetics osteoARthritis and Progres-
sion (GARP) study. Probands and siblings have OA at multiple joint sites in
the hands or OA in two or more of the following joint sites: hand, spine (cer-
vical or lumbar), knee, or hip. All were required to have symptomatic OA in at
least one joint site. The control group comprised 712 subjects (409 women,
303 men; mean age 59 years, range 30e79) that were frequency-matched to
the probands only for age ( 5 years) and geographic region. They were re-
cruited by random sampling of the population by telephone and not further
screened for the presence or absence of OA. The London collection com-
prised 317 controls (mean age 53 years, range 36e71) and 159 OA
(mean age 59 years, range 39e79) samples (all UK Caucasian women) se-
lected randomly (a subject from each twin pair with independence of the OA
status of the other twin) from the Twins UK registry of the Twin Research and
Genetic Epidemiology Unit in London. Hand osteoarthritis was deﬁned as 3
joints of both hands affected with osteoarthritis (n¼ 72). The deﬁnition for hip
as for knee OA was a K/L grade of 2 or higher in one or both knees (n¼ 71)
or one or both hips (n¼ 71; 5 of them also with OA in the knee). Patients and
controls from each collection gave their informed consent. Each collection of
samples has obtained the approval of the relevant ethics committee.
SNP prediction: The 18 ADAM and the 31 ADAMTS (except ADAMTS520)
proteaseswith available genome sequencewere searched for non-synonymous
SNPs (nsSNPs) in the dbSNPdatabase. The 152 nsSNPs that were foundwere
ﬁltered for validation status. Likely functional consequences of the validated
nsSNPs were assessed with two prediction softwares: SIFT (Sorting Intolerant
From Tolerant)31(available at http://blocks.fhcrc.org/sift/SIFT.html) that uses
alignment to orthologous and homologue protein sequences, and PolyPhen
(Polymorphism Phenotyping)32 (available at http://genetics.bwh.harvard.edu/
pph/index.html) that is based on empirical rules derived from phylogenetic and
structural information. Four nsSNPs were predicted as likely deleterious:
rs1054480 C/T in ADAMTS2, rs4747096 A/G in ADAMTS14, rs1019747 T/C
in ADAMTS16, and rs3740199 G/C in ADAM12. We also searched PubMED
for functional evidence of SNPs modifying ADAM or ADAMTS expression, but
none was found.
nsSNP Genotyping: The three sample collections of the ﬁrst set and the
Corunna collection were genotyped by multiplex single-base extension in
Santiago. PCR fragments were ampliﬁed in a multiplex PCR reaction (Qiagen
Multiplex PCR, Valencia, CA, USA). Oligonucleotide sequences and PCR
conditions are detailed in Supplementary Table I. Single-base extension reac-
tions were done with the SNaPshot Multiplex Kit (Applied Biosystems, Foster
City, CA, USA). The genotype call rate was 98.2% for all nsSNPs across sam-
ple collections and across patients and controls. Several samples with differ-
ent genotypes were sequenced to check for accuracy of results with the Big
Dye Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA). The
rs4747096 nsSNP was studied also in samples from the Leiden GARP and
London (Twins UK) collections. The Leiden samples were genotyped by
mass spectrometry (the homogeneous MassARRAY system; Sequenom,
San Diego, CA) using standard conditions (call rate 94 % cases, 97.7 % con-
trols). The London samples were genotyped (call rate 98.9 %) at Kbioscience
Ltd (Hertfordshire UK) using the KASPar chemistry, which is a competitive
allele-speciﬁc PCR genotyping system using ﬂuorescence resonance energy
transfer (FRET) quencher cassette oligonucleotides (http://www.kbioscien-
ce.co.uk/genotyping/genotyping-chemistry.htm).
Statistical analysis: A customized version of the Statistica (Statsoft, Tulsa
OK) software was used. Allele frequencies, odds ratios (O.R.) and their 95%
conﬁdence intervals (95% CI) were calculated. Comparison of allele frequen-
cies was done using two by two contingency tables with chi-square tests. This
statistic test was also used for carrier analysis, in which homozygotes for the
minor allele and heterozygotes were pooled together as the carrier group and
homozygotes for the major allele were the non-carrier group. Evidence of
a gene dose effect was evaluated with univariate logistic regression applying
an additive genetic model, in which the genotype of each subject is the inde-
pendent variable with values linearly increasing with allele dose (codes were:
0 for AA, 1 for Aa and 2 for aa genotypes). For stratiﬁcation analysis, female
patients were compared with female controls andmale patients with male con-
trols. Data from populations of Santiago, Thessaly and Oxford were combined
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collection of samples. This approach considers allele effect sizes in the form of
odds ratios but it does not pool allele frequencies and is not affected by hetero-
geneity in these frequencies. However, it requires homogeneity of effect size
(O.R.) across collections, which was assessed with the Breslow-Day test.
Power and sample size calculations were done with the Power and Sample
Size software for a value of a¼ 0.0533. The Leiden collection required speciﬁc
assays to compensate for familial relationships among the OA patients:
strength of association was assessed with logistic regression analysis per-
formed in STATA and robust standard errors were estimated from the variance
between sib pairs.
Results
Search for SNPs affecting function of any of the ADAM or
ADAMTS proteases (except ADAMTS5) led to selection of
four nsSNPs likely to have deleterious effects. These four
nsSNPs were studied in three sample collections that in-
cluded 1412 THR, 781 TKR, 242 HOA and 1185 control
samples from Santiago (Spain), Thessaly (Greece) and Ox-
ford (United Kingdom). Genotyping was successful in most
samples with results that were in Hardy-Weinberg equilib-
rium in each of the sample collections. Allele frequencies
showed that the nsSNPs rs1054480 in ADAMTS2 and
rs1019747 in ADAMTS16 were unrelated with any of the
OA phenotypes analyzed, TKR, THR or HOA both in
each of the individual collections (Table I) and in the
combined analysis of the three collections (Table II). These
results were not affected by gender stratiﬁcation.
Minor allele frequency (MAF) of the rs3740199 nsSNP in
ADAM12 was similar in cases and controls (Table I), but it
showed signiﬁcant MAF difference between THR men and
control men from the Santiago collection (60.8 % vs. 52.2
%, respectively, P¼ 0.04) although this difference was not
observed in men from the Oxford collection (53.8 % in
THR vs. 53.6 % in controls) or in the combined analysis
(O.R.M-H (odds ratio. Mantel-Haenszel)¼ 1.11, 95 % C.I
0.9e1.3; Table II).
The rs4747096 A/G nsSNP in ADAMTS14 was signiﬁ-
cantly associated to OA in two groups of patients (Table
I). The clearest difference was between patients with TKR
and controls from the Oxford collection (MAF 21.6 % vs.
16.0 %, respectively) that was predominant in women
(24.6 % vs. 15.7 % in cases and controls, respectively)
with an O.R. of 1.75 (95 % C.I¼ 1.3e2.4). Men from Oxford
showed not signiﬁcant difference (18.0 % vs. 16.4 % in
cases and controls, respectively). There was some indica-
tion of a dominant effect of the G allele in the Oxford’s
TKR women because the association was stronger in car-
rier analysis (O.R.¼ 2.05, 95% C.I. 1.4e3.0; P¼ 0.0001)
than in allelic analysis (above) or an additive genotype
model (O.R.¼ 1.78, 95% C.I. 1.3e2.4; P¼ 0.0003). TKR
samples from the Santiago collection showed also a modest
increase in the G allele frequency (Table I), but it was not
signiﬁcant. The Thessaly samples were neutral, or slightly
in the same direction than the Oxford samples (O.R. for
women¼ 1.10, 95% C.I.¼ 0.7e1.7). Pooled analysis of
the three groups of TKR patients showed signiﬁcant associ-
ation that was speciﬁc of women (Table II; O.R.M-H for
women¼ 1.41, 95 % C.I¼ 1.1e1.8). TKR men showed
a non-signiﬁcant increase in G allele frequency.
The second group of patients that showed signiﬁcant as-
sociation to the ADAMTS14 nsSNP was the HOA group
from Santiago, which was the unique available with this
phenotype. In this instance, the G allele was also more fre-
quent in patients than in controls (Table I; O.R.¼ 1.37, 95 %
C.I¼ 1.0e1.9), but the increase was similar in women
(O.R.¼ 1.43, 95 % C.I¼ 0.9e2.2) and men (O.R.¼ 1.47,
95 % C.I¼ 0.7e3.1). The minor allele of the ADAMTS14nsSNP also showed a trend to higher frequencies in the
two available groups of THR patients (Table I) and they
remained as a non-signiﬁcant trend (P¼ 0.08) in the com-
bined analysis (Table II).
Given the interesting results obtained with the rs4747096
ADAMTS14 nsSNP we extended our analysis to other col-
lections of OA samples (Table III). The Corunna samples
were of symptomatic knee OA and were compared with
the Santiago controls, as Santiago and Corunna share the
same population and are only 60 Km apart. This group
showed also a nominal increase in G allele frequency, but
only among women (17.9 % vs. 15.2 % in controls) and
this change was not signiﬁcant (O.R.¼ 1.21, 95 %
C.I.¼ 0.8e1.9). The samples from the GARP study have
been selected for sib pair concordance in a generalized
OA phenotype. They showed no change in the frequency
of the rs4747096 alleles. Finally, we obtained rs4747096
genotypes from some samples with radiographic OA of
the Twins UK registry. They did not show signiﬁcant fre-
quency changes (Table III), but this collection was the sin-
gle one in which OA patients showed a nominal decrease
in the MAF of the rs4747096 nsSNPs.Discussion
This study has examined OA genetic association with four
nsSNPs that likely are affectinggenesof potential importance
in OA, the ADAMTS and ADAM proteases.8,16,23e25 It was
not intended as a comprehensive assessment of these two
protease families because genetic variation in these genes
is much wider than the four nsSNPs studied here. Selection
of putative deleterious nsSNPs increases the chances of
ﬁnding association in a genetic study34,35. However, the
most likely outcome is lack of association even in this sub-
group of nsSNPs. In agreement with this expectation, we
did not ﬁnd association with three of the four nsSNPs studied,
in ADAMTS2, ADAMTS16 and ADAM12, respectively. Only
the ADAM12 rs3710199 nsSNP deserves a speciﬁc com-
mentary because this nsSNP has previously been studied
in relation with knee OA susceptibility. The minor allele was
associatedwith osteophytesandchange inosteophyte grade
in a prospective study of UK women with radiographic knee
OA25. A subsequent study in UK patients with symptomatic
knee OA showed no association with this nsSNP, although
a haplotype of the same gene was associated36. Our results
showed lack of association of this nsSNP with knee OA (as-
certained as TKR) and indicated that it is not associated to
THR or HOA. However, it should be noted that osteophyte
formation and other polymorphisms in the ADAM12 gene
were not investigated in our study.
In contrast, the rs4747096 nsSNP in ADAMTS14 showed
signiﬁcant association with some OA phenotypes, but not
with others. Association was clear in the TKR group, and
especially in women from the UK. In addition, association
was present in clinical hand OA, HOA. The strength of as-
sociation was similar in HOA and in TKR females as evalu-
ated by the O.R. (1.37 vs. 1.41, respectively). However, the
limited number of available HOA samples made this result
more uncertain than the obtained in TKR females. We
also noted a trend to association with the THR group. In
this case, the effect size was lower (O.R.¼ 1.14), but the
large sample size of our THR group (1412 patients) allowed
for better detection sensitivity. These are promising but not
deﬁnitive results. The association to TKR and HOA will re-
quire additional studies for conﬁrmation. Also additional
studies will be needed to delineate the effects that this
Table I
Minor allele frequencies of four putative damaging nsSNPs, rs1054480 in ADAMTS2, rs1019747 in ADAMTS16, rs3740199 in ADAM12 and rs4747096 in ADAMTS14, in patients with three OA
phenotypes, requiring joint replacement of the knee, TKR, or the hip, THR, or with hand OA, HOA, compared with controls without OA from three sample collections, Santiago, Thessaly and
Oxford. Minor allele percentages of the total group are followed by the separated women/men results
Collection Groupa ADAMTS2 ADAMTS16 ADAM12 ADAMTS14
T % P O.R. (95% C.I.) C % P O.R. (95% C.I.) C % P O.R. (95% C.I.) G % P O.R. (95% C.I.)
Santiago Control (n¼ 588, 230/358)a 29.7 31.3/28.8 36.0 34.8/36.9 55.6 60.9/52.2 16.2 15.2/16.8
TKR (n¼ 524, 422/102) 31.3 32.2/27.4 0.6 1.07 (0.8e1.4) 36.8 36.4/38.2 0.8 1.03 (0.8e1.3) 55.3 56.3/50.9 0.9 0.98 (0.8e1.2) 17.4 16.6/20.6 0.6 1.09 (0.8-1.5)
THR (n¼ 614, 370/242)b 26.5 25.0/29.2 0.2 0.85 (0.7e1.1) 36.3 37.4/35.0 0.9 1.01 (0.8e1.3) 58.8 57.6/60.8 0.3 1.14 (0.9e1.4) 18.4 18.8/17.9 0.3 1.17 (0.9-1.6)
HOA (n¼ 484, 426/54)b 28.1 28.9/24.1 0.6 0.92 (0.7e1.2) 33.5 33.9/29.6 0.4 0.89 (0.7e1.15) 57.3 57.8/51.8 0.6 1.06 (0.8e1.4) 20.9 20.4/23.1 0.047 1.37 (1.0-1.9)
Thessaly Control (n¼ 386, 274/112) 31.9 29.5/37.5 33.3 33.8/32.1 62.0 62.6/60.7 11.5 11.1/12.5
TKR (n¼ 318, 278/40) 35.9 35.4/40.0 0.3 1.19 (0.9e1.6) 29.6 28.8/35.0 0.3 0.84 (0.6e1.2) 56.7 58.4/45.0 0.2 0.80 (0.6e1.1) 11.4 12.1/7.5 1.0 0.99 (0.6-1.6)
Oxford Control (n¼ 1396, 712/684) 27.8 26.1/29.6 38.5 39.3/37.8 53.3 53.1e53.6 16.0 15.7/16.4
TKR (n¼ 720, 392/328) 28.2 27.0/29.5 0.9 1.02 (0.8e1.3) 36.1 37.8/34.3 0.4 0.90 (0.7e1.1) 51.4 52.4e50.3 0.4 0.93 (0.8e1.1) 21.6 24.6/18.0 0.001 1.44 (1.1-1.8)
THR (n¼ 2210, 1258/952) 28.8 28.0/29.8 0.5 1.05 (0.9e1.2) 41.2 40.3/42.4 0.1 1.12 (0.97e1.3) 54.7 55.5e53.8 0.4 1.06 (0.9e1.2) 17.8 16.9/19.0 0.2 1.13 (0.9e1.4)
an¼ total number of alleles, number of alleles from women/from men.
bA total of three samples lacked sex information.
Table II
Pooled analyses of the allele effect sizes (O.R.) corresponding to the three sample collections and the four putative damaging ADAMTS and ADAM nsSNPs of Table I in the patient groups with
TKR and THR. Analyses were done with the Mantel-Haenszel approach and including sex stratification
Groupa ADAMTS2 ADAMTS16 ADAM12 ADAMTS14
O.R.M-H
b (95 % C.I.) P PB-D
c O.R.M-H (95 % C.I.) P PB-D O.R.M-H (95 % C.I.) P PB-D O.R.M-H (95 % C.I.) P PB-D
TKR (n¼ 1562) (n ctrl¼ 2370) 1.06 (0.9e1.2) 0.4 0.7 0.9 (0.8e1.1) 0.4 0.5 0.92 (0.81e1.05) 0.2 0.6 1.25 (1.05e1.5) 0.009 0.2
TKR women (n¼ 1092) (n ctrl¼ 1216) 1.10 (0.9e1.3) 0.3 0.5 0.9 (0.8e1.1) 0.5 0.4 0.90 (0.75e1.06) 0.2 0.7 1.41 (1.1e1.8) 0.002 0.1
TKR men (n¼ 470) (n ctrl¼ 1154) 0.99 (0.8e1.3) 1.0 0.9 0.9 (0.7e1.2) 0.6 0.7 0.86 (0.69e1.07) 0.2 0.4 1.12 (0.8e1.45) 0.5 0.5
THR (n¼ 2824)d (n ctrl¼ 2370) 1.00 (0.9e1.1) 0.9 0.3 1.08 (0.96e1.2) 0.2 0.4 1.08 (0.96e1.21) 0.2 0.6 1.14 (0.98e1.3) 0.08 0.8
THR women (n¼ 1628) (n ctrl¼ 1216) 1.01 (0.8e1.2) 0.9 0.1 1.05 (0.9e1.2) 0.5 0.8 1.04 (0.89e1.23) 0.6 0.2 1.14 (0.9e1.4) 0.2 0.5
THR men (n¼ 1194) (n ctrl¼ 1154) 1.01 (0.8e1.2) 0.9 1.0 1.13 (0.95e1.3) 0.2 0.2 1.11 (0.94e1.32) 0.2 0.1 1.16 (0.9e1.5) 0.2 0.7
an¼ total number of alleles of Santiago, Thessalay and Oxford.
bMantel-Haenszel odds ratio.
cBreslow-Day heterogeneity test.
dOne sample (two alleles) haven’t got deﬁned sex.
3
2
4
J
.
R
o
d
rig
u
e
z
-L
o
p
e
z
e
t
a
l.:
A
D
A
M
T
S
1
4
p
o
ly
m
o
rp
h
is
m
in
O
A
s
u
s
c
e
p
tib
ility
325Osteoarthritis and Cartilage Vol. 17, No. 3ADAMTS14 nsSNP could have in other OA forms including
the THR group.
We already tried to obtain more information by analyzing
the ADAMTS14 nsSNP in other three sample collections.
Unfortunately, the results were inconclusive. The symptom-
atic KOA collection from Corunna showed a trend to in-
creased frequency of the G allele in the women’s group,
consistent with the observed in TKR women. No change
was observed in the generalized OA patients from the
GARP study or in the radiographic OA samples from the
Twins UK registry. These three collections were of different
OA phenotypes and each of them provided limited statistical
power. These two aspects make the results in these three
collections of uncertain interpretation. Available evidence
shows that each OA phenotype is dependent on different
genetic factors or with different strength1e3. In addition, ef-
fects of the ADAMTS14 nsSNP seem small and their dem-
onstration requires large studies. Sample sizes large
enough to detect an effect with O.R.¼ 1.3 and 80% power
were only available in the pooled analyses of TKR and of
THR patients because over 700 cases and 700 controls
are needed. The Corunna, Leiden and London collections
have only 39 %, 62 %, and 33 % power, respectively, for
this same effect.
Conﬁdence on the association between symptomatic
knee OA in women and ADAMTS14 genetic variation has
been reinforced by results of a WGAS done in the UK
and communicated in a recent meeting37. This study has
analyzed more than 400,000 SNPs spread over the ge-
nome in women knee OA patients and the SNPs showing
the largest differences were genotyped in additional collec-
tions of samples totalling more than 3,000 women. One of
the few SNPs that remained associated after replication
was a SNP in the forth intron of ADAMTS14 that showed
a pooled O.R.M-H¼ 1.2 (95 % C.I.¼ 1.02e1.41). This study
did not overlap with the samples included in our TKR collec-
tions. Therefore, two independent studies with a similar OA
phenotype and large sample sizes have found association
with SNPs in the ADAMTS14 gene. However, these concor-
dant results do not amount to replication because the SNPs
are different and not in linkage disequilibrium and conﬁrma-
tion in new studies is still required.
Further analyses will be also necessary to show the ef-
fects of the E1049G change in ADAMTS14 function and
to explore other ADAMTS14 polymorphims. Study of thisTable I
Minor allele frequencies of the ADAMTS14 nsSNPs rs4747096 in three sa
II. These collections included patients with varied OA phenotypes: symptom
in the Leiden collection and women with radiographic OA in the London c
the separated wome
Collection Groupa
Corunna Controlsb (n¼ 588, 230/358) 1
KOA (n¼ 530, 444/86) 1
Leiden Controls (n¼ 1424, 818/606) 1
GARP (n¼ 716, 584/132) 1
Londonc Controls (n¼ 634) 1
ROA (n¼ 318) 1
an¼Number of alleles, number of alleles from women/from men;
GARP¼Genetics, Arthrosis and Progression, sib pairs concordant for OA
bControls from the Santiago collection.
cAll samples of this collection are from women.gene will not be easy because its 22 exons are spread
over 89.6 Kb in chromosome 10q22.1 and because little is
still known about ADAMTS14 function38e40. The
rs4747096 nsSNP determines a change of glutamic acid
for glycine in a segment of the protein of unclear functional
signiﬁcance. It was predicted as damaging by PoylPhen,
a software application with speciﬁcity over 90 %41. It pro-
vides a global evaluation but does not indicate the likely
damaging effect. A clue of the possible functional relevance
was obtained by comparative phylogenetic analysis. A glu-
tamic acid in this position is exclusive of the human
ADAMTS14 gene. Glycine is the ancestral allele as this is
the amino acid in ADAMTS14 orthologues in chimpanzee
and rhesus macaque. However, the glutamic acid allele is
more common than the glycine allele in Europeans, Afri-
cans and Asians, raising the possibility of some advantage
associated to it that will have favored its positive selection in
humans. However, little else can be said until more is
known on ADAMTS14 function. Most available information
has been inferred by its similarity to two other ADAMTS,
ADAMTS-2 (56 %) and -3 (63 %)40. The three are able to
cleave the N-telopeptides of procollagen, a process that
takes place in collagen monomers before they are incorpo-
rated into ﬁbers. Expression of the three propeptidases has
been found to be up-regulated in OA cartilage23,24. This
over-expression can be related with cartilage repair and
production of matrix components as part of the anabolic
compensation to cartilage degradation. ADAMTS14 is pro-
duced in a latent form and, after activation, it processes pro-
collagen I in an in vitro system. However, no other
substrates have been examined and its natural in vivo sub-
strate is unknown40. The relevance of ADAMTS14 activity
on procollagen I processing is unclear as it is not able to re-
place ADAMTS2 deﬁciency in Ehlers-Danlos syndrome
type VIIC42.
In conclusion, we have found that a change of glutamic
acid for glycine in ADAMTS14 was associated with women
knee OA requiring joint replacement and with clinical hand
OA. The ﬁrst association was more robust because of the
larger sample size and because of evidence from other
study of association between ADAMTS14 genetic variation
and symptomatic knee OA in women. Our results suggest
also that the same nsSNP could have association, but
weaker, with hip OA requiring prosthesis. These results re-
quire conﬁrmation in well powered studies. Also,II
mple collections that are different from the analyzed in Tables I and
atic knee OA in the Corunna collection, familial OA at multiple sites
ollection. Minor allele percentages of the total group are followed by
n/men results
ADAMTS14
G % P O.R. (95% C.I.)
6.2 15.2/16.8
6.7 17.9/10.7 0.8 1.04 (0.75e1.4)
6.9 16.4/17.7
7.5 16.6/21.2 0.8 1.04 (0.8e1.3)
8.6
5.4 0.2 0.79 (0.55e1.15)
KOA¼ sympthomatic and radiographically conﬁrmed knee OA;
at multiple sites; ROA¼ radiographic OA of the hand, knee or hip.
326 J. Rodriguez-Lopez et al.: ADAMTS14 polymorphism in OA susceptibilitya systematic study of ADAMTS14 variation should be done
to uncover possible additional polymorphisms. Other OA
phenotypes we have examined showed lack of association.
The incomplete knowledge of ADAMTS14 functions ham-
pers prediction of its possible role in OA, but it is likely
that deﬁcient ADAMTS14 could lead to incompletely pro-
cessed collagen that will cause detrimental effects on carti-
lage matrix structure and function.Conﬂict of interest
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